businessagent.com 2018
Fully funded

EIS
businessagent.com 2018
Partner Premium Claimed
Business Agent* is an FCA approved aggregation and rating portal for equity and debt crowdfunding investments. AIM is shrinking, legacy stock markets are too expensive to maintain and do not serve the requirements of SMEs, banks are closing branches, lending less and are paying little or no interest to investors. As a result of this there is a huge growth in equity crowdfunding and P2P lending which has seen the launch of hundreds of alternative lenders & platforms that has created a new c.£3bn marketplace, expanding at 66% p.a. There is no single portal or trusted ratings index for investors to compare on a like for like basis and no secondary market to facilitate exits.   * NextFin is the new trading name of Business Agent Ltd The solution NextFin aggregates equity and debt crowdfunding investments to create the alternative finance marketplace. This makes it easy for investors and lenders to find and compare opportunities by presenting all investment offerings in one place. With the addition of a free of charge ratings service investors will be able to view ratings of every equity crowdfunding pitch, every P2P site, and every equity crowdfunding site. NextFin’s technology will constantly track these companies and investments providing the investor real-time intelligence on which to base investment decisions. The platforms and entrepreneurs will be self promoting and marketing their ratings driving thousands of visitors a month to the NextFin site, in the same way businesses refer their potential clients to Trip Advisor and Trustpilot. There is an estimated 10 million website/platform visitors per month across the whole of the alternative finance market. NextFin is targeting to direct 5% of this highly profiled traffic to its platform from which it will earn between £5-£8 per click from advertisers and partners. In addition an in-house brokerage service also earns between 1%-6% commissions on loan placements. A future revenue stream (not featured in the financials) will be developed once visitor traffic reaches critical mass. This will see Nextfin being able to realise the full value of its captured ratings data and visitor traffic by launching a secondary market, which is estimated to be a £5bn marketplace. NextFin is raising £500k at a pre-money valuation of £800k to: • Acquire CrowdRating for a non cash consideration of 20% equity• Develop P2P and Equity site ratings• Expand the management, infrastructure and marketing resource• Increase visitor traffic to 6m a year via rating referrals Owing to the size of the market and rapid growth of the industry, enterprise valuations in alternative finance are based on visitor traffic, market share and registered users. Recent published valuations of companies with visitor traffic of over 6m per year are in excess of £70m. NextFin is the market leading aggregator and has first mover advantage. It has the potential to exceed these valuations because it is the whole of market aggregator and is currently the only ratings service provider as it grows to achieve 500,000 visitors p.m.
investment: £382,391
investors: 8 • status: Active
Model Office
Fully funded

EIS
Model Office
Partner Premium Claimed
A compliance service allowing financial organisations to benchmark their businesses against legal regulations. Model Office integrates with existing infrastructures to identify issues in a firm's due diligence records. The service then offers guidance, strategies, solutions and resources to ensure the business is fully compliant with regulations. In addition, firms can also run the software on clients to confirm they also meet FCA and ICO rules as a safety and insurance measure. Model Office offers multiple versions of their products for customers with particular needs for a recurring monthly subscription. A full version consists of the benchmarking and audit tools, whilst an Enterprise adds an AI chat bot for further assistance, amongst many other features.
investment: £150,000
investors: 2 • status: Active
Score Genius
Fully funded

EIS/SEIS
Score Genius
Partner Premium Claimed
A financial management software application for consumers to view everything from credit files and bank accounts, to vouchers and cashbacks. Score Genius aims to launch an Alpha version of their product at the end of 2018, with a public release planned for March 2019. The service will offer users the ability to monitor their credit files and perform transactions on their bank accounts and credits, as Open Banking will be integrated into the platform. Score Genius is near completion of negotiations with large technological partners. Investments will used to market the platform and further develop features and functions, ready for the public release in 2019. Revenue streams will be comprised of advertisements, redeeming vouchers and users looking to switch their energy.
investment: £144,920
investors: 136 • status: Active
Safe Solvents
Fully funded

EIS
Safe Solvents
Partner Premium Claimed
An engineering parts washing company using environmentally friendly aqueous solvent technology to clean components. As of January 2018, Safe Solvents uses a service model to generate income. The company has currently signed 131 contracts with businesses in the engineering sector and is expecting to sign almost 20 more by the end of their financial year in February 2019. Safe Solvents has patented their technology and is aiming to achieve an 8% market share within the next 5 years in the UK. The company is now raising funds to expand further in the UK, as well as enter the global market. In addition, Safe Solvents is currently developing 4 new products with many more in the pipeline and the company is also seeking to enter other industries that can benefit from the technology.
investment: £1,110,070
investors: 299 • status: Extended
Handbag Clinic
Fully funded

EIS
Handbag Clinic
Partner Premium Claimed
Buying, selling and restoring designer handbags across the UK, Middle East and Monaco. Since launching in 2013, Handbag Clinic has cleaned and restored £30m worth of bags, including major labels such as Hermes and Chanel. The bags are purchased from their customers and are then sold at 50% of the RRP, making luxury fashion affordable. The company has their own independent stores and their services are also used by Harvey Nichols and Harrods. Clients of the business include Gucci, Dior, D&G, Jimmy Choo and many others. Handbag Clinic achieved sales of £1m in 2018. In December 2018 alone, the sales of handbags exceeded £100,000. Handbag Clinic currently lists more than 500 bags on their e-commerce platform and are now raising funds to acquire more bags, redevelop their website and increase their brand awareness through marketing campaigns.
investment: £269,200
investors: 282 • status: Extended
Renovagen
Fully funded

EIS
Renovagen
Partner Premium Claimed
Portable solar power technology, primarily used in life-saving emergency situations and military operations. Renovagen has developed a lightweight energy system that is quickly deployable and simple to use. The technology can be used in remote locations, with little or no access to an energy source and can be used to power medical tools and equipment. Their products have been utilised at off-grid sites in the Middle East, India, Africa and North America. Customers of the business include worldwide governments, NGOs, Royal Marines, UN Agencies and international charities. Renovagen's FAST FOLD product has already received over £200k in orders within the last 5 months. The company has now completed a £400k contract for their patented RAPID ROLL product. This funding round will enable Renovagen to meet customer demand by increasing production speed and inventory levels.
investment: £374,530
investors: 672 • status: Extended
Belluscura
Fully funded

EIS
Belluscura
Partner Premium Claimed
Belluscura is an Oxygen Enrichment Company focussed on innovative oxygen solutions that will improve the lives of millions. Belluscura has developed the X-PLOR, a lightweight, portable oxygen delivery device aimed at treating the millions of people globally suffering from chronic lung diseases. The company plans to launch this novel and cost-effective device in the US in 2019, with Europe to follow. It plans to expand its proprietary oxygen platform technology into other multi £bn markets such as sleep and wound care. Moreover, they have filed patents on a next-generation portable artificial lung.
investment: £245,960
investors: 56 • status: Active
OPUMO
Fully funded

EIS
OPUMO
Partner Premium Claimed
OPUMO provides a zero-inventory digital marketplace to stores and allows them to reach the customers easily. As a departmental store of the future, OPUMO caters to customers who are looking for the latest fashion, art, furniture, technology and many more, on the tip of their fingers. This platform was launched in March 2017, and up till now has witnessed sales worth £2.3m.
investment: £354,000
investors: 279 • status: Extended
iContract
Fully funded

EIS
iContract
Partner Premium Claimed
icontract is an online platform that connects professional contractors with recruiters and employers for job matching, professional networking and contract management.  The platform has live profiling, targeted search, connections and instant messaging.  With a proprietary algorithm that makes recommendations based on availability, skill set and day rate. 
investment: £117,458
investors: 161 • status: Active
CELLMED
Fully funded

EIS
CELLMED
Partner Premium Claimed
Cellmed is an immuno-oncology company that are developing treatments for ovarian cancer.  Their lead product PROCURE a dendritic cell vaccine and they are now looking to expand the treatment to target solid tumors.    
investment: £520,294
investors: 21 • status: Stretch